Catalent Inc. (CTLT) Stock: Tracking the Weekly Performance

Biotech Stocks to buy

The stock of Catalent Inc. (CTLT) has seen a -2.21% decrease in the past week, with a -0.35% drop in the past month, and a 14.78% flourish in the past quarter. The volatility ratio for the week is 0.99%, and the volatility levels for the past 30 days are at 0.84% for CTLT. The simple moving average for the last 20 days is -1.14% for CTLT’s stock, with a simple moving average of 17.17% for the last 200 days.

Is It Worth Investing in Catalent Inc. (NYSE: CTLT) Right Now?

The 36-month beta value for CTLT is at 1.18. Analysts have varying views on the stock, with 3 analysts rating it as a “buy,” 4 rating it as “overweight,” 4 as “hold,” and 0 as “sell.”

The public float for CTLT is 175.08M, and currently, shorts hold a 4.29% of that float. The average trading volume for CTLT on April 17, 2024 was 2.71M shares.

CTLT) stock’s latest price update

Catalent Inc. (NYSE: CTLT)’s stock price has dropped by -0.03 in relation to previous closing price of 55.78. Nevertheless, the company has seen a loss of -2.21% in its stock price over the last five trading days. Reuters reported 2024-04-08 that The parent of Wegovy producer Novo Nordisk has refiled an application to the U.S. Federal Trade Commission (FTC) for approval of a $16.5 billion deal to buy manufacturing subcontractor Catalent, a spokesperson said on Monday.

Analysts’ Opinion of CTLT

Many brokerage firms have already submitted their reports for CTLT stocks, with Robert W. Baird repeating the rating for CTLT by listing it as a “Outperform.” The predicted price for CTLT in the upcoming period, according to Robert W. Baird is $53 based on the research report published on November 16, 2023 of the previous year 2023.

Argus, on the other hand, stated in their research note that they expect to see CTLT reach a price target of $62. The rating they have provided for CTLT stocks is “Buy” according to the report published on September 05th, 2023.

Wells Fargo gave a rating of “Equal Weight” to CTLT, setting the target price at $43 in the report published on July 20th of the previous year.

CTLT Trading at -2.05% from the 50-Day Moving Average

After a stumble in the market that brought CTLT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -7.37% of loss for the given period.

Volatility was left at 0.84%, however, over the last 30 days, the volatility rate increased by 0.99%, as shares sank -0.19% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -6.64% lower at present.

During the last 5 trading sessions, CTLT fell by -2.06%, which changed the moving average for the period of 200-days by +28.79% in comparison to the 20-day moving average, which settled at $56.40. In addition, Catalent Inc. saw 24.11% in overturn over a single year, with a tendency to cut further gains.

Insider Trading

Reports are indicating that there were more than several insider trading activities at CTLT starting from Gunther Scott, who sale 387 shares at the price of $56.20 back on Mar 15 ’24. After this action, Gunther Scott now owns 29,506 shares of Catalent Inc., valued at $21,749 using the latest closing price.

Ryan Michelle R, the Director of Catalent Inc., purchase 1,000 shares at $49.98 during a trade that took place back on Aug 31 ’23, which means that Ryan Michelle R is holding 1,979 shares at $49,980 based on the most recent closing price.

Stock Fundamentals for CTLT

Current profitability levels for the company are sitting at:

  • -0.21 for the present operating margin
  • 0.19 for the gross margin

The net margin for Catalent Inc. stands at -0.3. The total capital return value is set at -0.1. Equity return is now at value -29.72, with -12.09 for asset returns.

Based on Catalent Inc. (CTLT), the company’s capital structure generated 0.58 points at debt to capital in total, while cash flow to debt ratio is standing at 0.04. The debt to equity ratio resting at 1.36. The interest coverage ratio of the stock is -3.83.

Currently, EBITDA for the company is 79.0 million with net debt to EBITDA at -79.75. When we switch over and look at the enterprise to sales, we see a ratio of 3.62. The receivables turnover for the company is 3.01for trailing twelve months and the total asset turnover is 0.41. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.48.

Conclusion

In conclusion, Catalent Inc. (CTLT) has had a mixed performance lately. Opinion on the stock among analysts is mixed, with some giving it a “buy” rating and others a “hold”. It is worth mentioning that the stock is currently trading in close proximity to its 50-day moving average and its 52-week high.

Most Popular

Related Posts